Prospective study of 288 episodes of bacteremia in neutropenic cancer patients in a single institution

Eur J Clin Microbiol Infect Dis. 1996 Apr;15(4):291-6. doi: 10.1007/BF01695660.

Abstract

Trends in causative organisms and sources of infection were studied in a series of 288 episodes of bacteremia in neutropenic cancer patients observed in a single institution from 1986 to 1993. The incidence of bacteremia increased significantly from 20 episodes per 1000 admissions in 1986 to 50 episodes per 1000 admissions in 1993 (p = 0.00001). Over the study period, a continuous increment in gram-positive bacteremia, which reached 81% of episodes in 1993 (p = 0.000001), was observed. Conversely, the incidence of gram-negative bacteremia remained stable. Coagulase-negative staphylococci and viridans group streptococci were the most commonly isolated pathogens. Bacteremia caused by coagulase-negative staphylococci increased from 3 episodes per 1000 admissions to 19 episodes per 1000 admissions (p = 0.0001), and viridans group streptococci bacteremia increased from 0 episodes per 1000 admissions to 19 episodes per 1000 admissions (p = 0.000001). The upward trend in gram-positive bacteremia appeared to be related to a significant increase in both intravascular catheters (p = 0.003) and oral mucositis (p = 0.003) as sources of infection. Specific strategies to prevent chemotherapy-induced mucositis and catheter-related bacteremia merit further investigations.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adolescent
  • Adult
  • Aged
  • Aged, 80 and over
  • Bacteremia / epidemiology*
  • Bacteremia / etiology
  • Bacteremia / microbiology
  • Bacteremia / mortality
  • Escherichia coli Infections / epidemiology*
  • Escherichia coli Infections / etiology
  • Escherichia coli Infections / microbiology
  • Escherichia coli Infections / mortality
  • Female
  • Humans
  • Incidence
  • Leukemia / complications
  • Male
  • Middle Aged
  • Neoplasms / complications*
  • Neutropenia / etiology*
  • Prospective Studies
  • Pseudomonas Infections / epidemiology*
  • Pseudomonas Infections / etiology
  • Pseudomonas Infections / microbiology
  • Pseudomonas Infections / mortality
  • Staphylococcal Infections / epidemiology*
  • Staphylococcal Infections / etiology
  • Staphylococcal Infections / microbiology
  • Staphylococcal Infections / mortality
  • Streptococcal Infections / epidemiology*
  • Streptococcal Infections / etiology
  • Streptococcal Infections / microbiology
  • Streptococcal Infections / mortality
  • Time Factors